Why MetLife Stock Is Back in Focus After Earnings and Buyback News

MetLife (MET) is on investors’ radar after second quarter 2026 results, a fresh look at its New Frontier strategy, and a new US$3b share repurchase authorization announced on 5 August 2026.

At a share price of US$97.47, MetLife has seen a 22.17% 90 day share price return and a 28.66% 1 year total shareholder return. This suggests building momentum as investors react to recent earnings, the expanded buyback and progress under the New Frontier strategy.

If MetLife’s buyback and earnings story has your attention, this is also a useful moment to look at other areas of the market and see 20 top founder-led companies

After MetLife’s recent strong run and the announcement of a fresh US$3b buyback plan, the key question for investors is whether to lock in exposure now or wait for a potential pullback. How does the current price compare with the underlying fundamentals?

Most Popular Narrative: 3% Undervalued

MetLife’s most followed narrative puts fair value at $100.44 a share, a touch above the latest close at $97.47, which keeps the valuation debate very much alive.

Strategic expansion of asset-light, fee-generating businesses (like employee benefits, asset management, and longevity reinsurance), combined with disciplined capital management, supports higher return on equity and more consistent, less capital-intensive earnings growth.

Early leadership and scale in growth platforms and partnerships (Chariot Re, PineBridge acquisition, digital embedded insurance platforms in LatAm) allow MetLife to capture outsized share in emerging product and distribution opportunities, enhancing future revenue streams and contributing positively to long-term earnings quality.

Want to see what is really backing that fair value on MetLife? The narrative leans on compound revenue growth, rising margins and a lower earnings multiple that still assumes robust profitability.

Result: Fair Value of $100.44 (UNDERVALUED)

However, investors also need to weigh risks such as compressed investment yields affecting MetLife’s portfolio returns, as well as commercial mortgage loan credit losses pressuring capital and earnings resilience.

Another View on MetLife’s Valuation

MetLife may screen as about 3% undervalued on fair value estimates, yet the current P/E of 18x tells a different story. That is higher than the US Insurance industry on 11.3x, peers on 12.7x and even above a 15.9x fair ratio that the market could move towards. This premium points to valuation risk if sentiment cools.

For a closer look at how the current price stacks up against earnings-based checks, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With mixed signals on valuation, buybacks and growth for MetLife, it helps to see exactly what the data says for yourself. Move quickly to review the balance of potential upsides and downsides by checking the 3 key rewards and 1 important warning sign.

Looking For More Investment Ideas Beyond MetLife?

If MetLife has sharpened your focus on quality opportunities, do not stop here. Use the Simply Wall Street Screener to uncover more ideas before the crowd does.

• Capture potential upside by scanning for companies that look priced below their fundamentals using the 51 high quality undervalued stocks.
• Strengthen your income stream by reviewing stocks with robust payouts and resilience through the 11 dividend fortresses.
• Protect your capital by filtering for businesses with healthier finances and steadier profiles via the 88 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.